News
TOKYO, March 31, 2025 /PRNewswire/ -- Luye Pharma Group today announced that marketing approval for its innovative formulation Rivastigmine Twice Weekly Transdermal Patch has been granted by the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback